Novabio (france laboratories) Listed by nova Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Inside the incident

The incident centers on a claim posted by the nova group that it obtained data from Novabio. Public reporting to date provides no verified timeline for when the intrusion occurred, how access was gained, or whether encryption was deployed alongside the exfiltration. The only confirmed detail is the appearance of the organization on the group’s leak site on the reported date.

The group behind it: nova

Nova is a ransomware operation that maintains a public leak site to pressure victims. The group typically claims to have stolen files before encrypting systems and then publishes samples or directories to encourage payment. Its listings are presented by the group itself; independent verification of the data’s authenticity or completeness is not provided in the listing for Novabio.

Who is Novabio (france laboratories)?

Novabio operates as a medical biology laboratory serving patients and physicians in regions including Dordogne and Gironde. Laboratories of this type perform diagnostic testing and maintain records that include patient identifiers, test results, and related administrative information. A breach at such a facility can affect both individual health privacy and the continuity of local medical services.

What was likely exposed

The listing describes internal files and states that the exfiltrated material totals 500 GB across millions of files, including PDFs, DOCs, XLSx, SQL files, and SSH keys. It further claims the data encompasses patient information, doctor details, partner records, financial data, and screening results. These descriptions originate from the group’s post; the precise contents and whether every category is present have not been independently confirmed.

What's at stake

Exposure of medical test results and associated personal details can lead to privacy harms for individuals and may complicate ongoing clinical work for referring physicians. For the laboratory, the incident raises questions about operational resilience and regulatory obligations tied to health data. No specific evidence of subsequent misuse has been reported at this stage.

What to do if you're exposed

Individuals who receive notification from Novabio or suspect their information may be involved should monitor statements from the laboratory and follow any guidance it issues. Basic steps include changing passwords for any linked accounts, enabling multi-factor authentication, and reviewing financial and medical statements for anomalies. Readers can run a free exposure scan of their email address against known breach data to check for prior appearances in public listings.

AICompiled with AI assistance from public sources and published under our editorial standards.